Heartflow, Inc
Price
FilingsNewest: 10-Q, Quarterly reportAug 13 →Insiders1 insider bought $1.1M in 1 open-market buy. 8 insiders sold $123.6M, 12 of 17 sales on a 10b5-1 plan.→HoldersBain Capital Life Sciences Investors 9.7%Wellington Management Group LLP 9.1%BlackRock 6.0%→PeersClosest companies: LUNG, ADGM, ACON→
From the filings
Figures
- Revenue
- $212.1Mlast 12 months
- Net income
- −$118.4Mlast 12 months
- Operating cash flow
- −$71.0Mlast 12 months
- Cash and equivalents
- $34.4Mat the last balance sheet
- Shares outstanding
- 86.7M shareson issue